Hospira Propofol Injectable Emulsion: Recall - Glass Vial Defect
MedSun: Newsletter #76, September 2012

FDA MedWatch Safety Alert

Recall due to visible particles embedded in the glass to the user level. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. In the event in which particulate matter could be injected into a patient, there may be the potential for patient injury where medical intervention may be required

Additional Information:

FDA MedWatch Safety Alert. Hospira Propofol Injectable Emulsion: Recall - Glass Vial Defect. August 16, 2012.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315746.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun